{"name":"SLS Venture","permalink":"sls-venture","crunchbase_url":"http://www.crunchbase.com/financial-organization/sls-venture","homepage_url":"http://www.slsventure.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"46-8-5450-7030","description":"","email_address":"info@slsinvest.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Oct 13 02:05:01 UTC 2009","updated_at":"Wed Dec 30 11:37:58 UTC 2009","overview":"<p>SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus.</p>\n\n<p>The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. â‚¬ 270 M (USD 325 M) under management.</p>","image":{"available_sizes":[[[150,28],"assets/images/resized/0007/1578/71578v1-max-150x150.png"],[[250,47],"assets/images/resized/0007/1578/71578v1-max-250x250.png"],[[250,47],"assets/images/resized/0007/1578/71578v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"SVEAVÃ„GEN 17, 11 TR.","address2":"","zip_code":"SE-111 57","city":"STOCKHOLM","state_code":null,"country_code":"SWE","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"Partner and CEO ","person":{"first_name":"Per","last_name":"Carendi","permalink":"per-carendi","image":{"available_sizes":[[[128,150],"assets/images/resized/0007/1579/71579v1-max-150x150.jpg"],[[204,238],"assets/images/resized/0007/1579/71579v1-max-250x250.jpg"],[[204,238],"assets/images/resized/0007/1579/71579v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"CFO and Partner ","person":{"first_name":"Mikael","last_name":"Mortensen","permalink":"mikael-mortensen","image":{"available_sizes":[[[130,150],"assets/images/resized/0007/1580/71580v1-max-150x150.jpg"],[[203,234],"assets/images/resized/0007/1580/71580v1-max-250x250.jpg"],[[203,234],"assets/images/resized/0007/1580/71580v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner and Managing Director","person":{"first_name":"Henrik","last_name":"Lawaetz","permalink":"henrik-lawaetz","image":{"available_sizes":[[[119,150],"assets/images/resized/0007/1581/71581v1-max-150x150.jpg"],[[178,223],"assets/images/resized/0007/1581/71581v1-max-250x250.jpg"],[[178,223],"assets/images/resized/0007/1581/71581v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/advandx-inc-series-c-8m/","source_description":"AdvanDx, Inc.: Series C $8M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":12,"company":{"name":"AdvanDx","permalink":"advandx","image":{"available_sizes":[[[150,35],"assets/images/resized/0006/2552/62552v1-max-150x150.jpg"],[[151,36],"assets/images/resized/0006/2552/62552v1-max-250x250.jpg"],[[151,36],"assets/images/resized/0006/2552/62552v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.oxthera.com/pr.php?no=2","source_description":"OxThera Raises SEK 150 Million in New Round of Financing","raised_amount":150000000,"raised_currency_code":"SEK","funded_year":2007,"funded_month":6,"funded_day":29,"company":{"name":"OxThera","permalink":"oxthera","image":{"available_sizes":[[[127,45],"assets/images/resized/0008/0099/80099v1-max-150x150.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-250x250.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.oxthera.com/pr.php?no=3","source_description":"External financing of SEK 165 million secured for Q-Med's oxalate project","raised_amount":165000000,"raised_currency_code":"SEK","funded_year":2005,"funded_month":7,"funded_day":11,"company":{"name":"OxThera","permalink":"oxthera","image":{"available_sizes":[[[127,45],"assets/images/resized/0008/0099/80099v1-max-150x150.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-250x250.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/action-pharma-as-series-c-63m/","source_description":"Action Pharma, A/S: Series C $6.3M","raised_amount":6300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":16,"company":{"name":"Action Pharma","permalink":"action-pharma","image":null}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}